Given that AG is known to stimulate the release of GH from the pituitary gland, accumulating evidence has unanimously indicated a potential interplay of the ghrelin-GH pathway in the development of obesity and hypertension. This evidence concerns the gene GHRL and obesity due to melanocortin 4 receptor deficiency.